Market News & Trends
Pharmaceutical Industry Feeling Force of Tax Inversion Legislation, says GlobalData Analyst
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the…
Horizon Discovery Group Launches Collection of Highly Characterized Patient-Derived Xenograft Models of Breast Cancer
Horizon Discovery Group plc (Horizon), a leading provider of products, services and technologies in the field of genome engineering, today announced the launch of its…
Aduro Expands Collaboration With J&J Innovation & Janssen
Aduro BioTech, Inc. recently announced that it has entered into its second agreement with Janssen Biotech, Inc., part of the Janssen Pharmaceutical Companies of Johnson…
Zynerba Pharmaceuticals Raises $13 Million to Develop First & Only Transdermal Cannabinoid Therapies
Zynerba Pharmaceuticals, Inc. recently announced the successful closing of $13- million in funding. New investors in Zynerba include one of the top-seven life sciences public…
Raze Therapeutics Launches With $24-Million to Advance New Class of Oncology Therapeutics
Raze Therapeutics recently announced the closing of a $24-million Series A financing. Proceeds from the financing will be used to advance the development of a…
Auspherix & Domainex Announce Major Development Collaboration
Domainex Ltd. and Auspherix Pty Ltd recently announced a collaboration that will progress Auspherix’s novel anti-infective drug discovery program toward the nomination of a…
Horizon Discovery Group Signs Agreement With Top 10 Pharma Company
Horizon Discovery Group plc recently announced that its Horizon CombinatoRx division has been contracted by a top 10 pharma company to profile a lead oncology…
Endo Acquires Company for $2.6 Billion
Endo International plc and Auxilium Pharmaceuticals, Inc. recently announced they have entered into a definitive agreement under which Endo will acquire all of the outstanding…
Oxford BioMedica Announces Development & Manufacturing Collaboration With Novartis
Oxford BioMedica plc, a leading gene and cell therapy company, recently announced today it has signed further contracts with Novartis that build on the previous…
OsteoSymbionics Announces Significant FDA 510(k)
OsteoSymbionics, innovative designer and manufacturer of patient-specific craniofacial implants, is pleased to announce the US FDA 510(k) clearance for sterile processing of its signature ClearShield…
West Announces Plans to Expands Global Capabilities to Meet Demand
West Pharmaceutical Services, Inc. recently announced it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility…
Capsugel Expands Its Lipid Multi-Particulate Technology Offering
Capsugel recently announced the broad commercial availability of its proprietary lipid multi-particulate (LMP) technology. Capsugel’s LMP technology is an innovative drug delivery platform with multiple…
Exostar Receives $5-Million Investment From Merck GHI
Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, recently announced a $5-million investment to enable them to accelerate…
Progenics Receives $40-Million Milestone
Progenics Pharmaceuticals, Inc. recently announced it received a $40-million milestone payment from its worldwide collaboration partner, Salix Pharmaceuticals, Ltd. upon the US FDA’s recent approval…
Changes & Trends in Solubilization Outsourcing
By: Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc. Approved drugs over the last thirty-five years are evidence that there is a…
West Pharmaceutical Services & HealthPrize Technologies Join Forces
West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC recently announced a strategic collaboration to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient engagement platform with…
Catalent Expands Technology Offerings in Biologics, Acquires Redwood Bioscience
Catalent Pharma Solutions recently announced it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag Antibody-Drug Conjugate (ADC) technology platform. In Catalent’s…
Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization & Glycoprotein Biosynthesis
Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the USA under ICH Q7-compliant conditions. “Mannose has long been recognized…
SGS Life Science Services Announces New Facility
SGS Life Science Services recently announced further investment in the French market, with a new facility in Villeneuve la Garenne. The new location, which will…